Psychemedics Announces First Quarter Results and Declares 91st Consecutive Quarterly Dividend
23 avr. 2019 17h25 HE
|
Psychemedics Corporation
ACTON, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2019. The Company also...
New Psychemedics Offering Further Enhances Cocaine Detection
27 mars 2019 13h46 HE
|
Psychemedics Corporation
SAN ANTONIO, TX and ACTON, MA, March 27, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader in detecting drugs of abuse using hair analysis, today at the National Drug...
Psychemedics Corporation Announces 3rd Straight Year of Record Revenue; Declares 90th Consecutive Quarterly Dividend
04 mars 2019 17h15 HE
|
Psychemedics Corporation
ACTON, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2018. The...
Psychemedics Announces Quarterly Results
23 oct. 2018 17h30 HE
|
Psychemedics Corporation
Declares 89th Consecutive Quarterly Dividend ACTON, Mass., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period...
Psychemedics Announces 2Q Record Revenues
24 juil. 2018 17h30 HE
|
Psychemedics Corporation
ACTON, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2018. The Company also announced...
James Abely Promoted to VP and General Counsel at Psychemedics Corporation
08 mai 2018 10h00 HE
|
Psychemedics Corporation
ACTON, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair analysis drug testing, today announced that James Abely has been promoted...
Psychemedics Corporation Announces New Vice President, Sales and Marketing
02 mai 2018 13h00 HE
|
Psychemedics Corporation
ACTON, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) announced the appointment of Charles M. Doucot as the Company's Vice President, Sales and Marketing. Mr. Doucot...
Psychemedics Announces 1Q Record Revenues and Dividend Increase of 20%
24 avr. 2018 17h15 HE
|
Psychemedics Corporation
ACTON, Mass., April 24, 2018 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2018. The Company also...
Psychemedics Corporation Announces Q4 and Year End Results
07 mars 2018 17h00 HE
|
Psychemedics Corporation
ACTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced fourth quarter and year-end financial results for the period ended December 31, 2017. The...